Gene therapy for blood disorders such as sickle cell disease and beta thalassemia switch on fetal hemoglobin and replace ...
September is Sickle Cell Awareness Month, bringing attention to a genetic blood disorder that affects about 100,000 people in ...
Harvard Medical School researchers at Boston Children's Hospital and Dana-Farber Cancer Institute have identified a new ...
Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen to all the different tissues in your body and removing carbon dioxide to ...
The initiative aims to take early diagnosis, genetic counselling, and specialised treatment to remote tribal pockets that ...
An exploration of large patient biobanks linked to clinical information has revealed new health conditions associated with sickle cell trait, the status of carrying just one beta globin gene with the ...
Sickle cell disease is an inherited blood disorder. People are born with the disease because they inherit abnormal hemoglobin genes from both parents. Learning how sickle cell disease is inherited can ...
HBB-β S: An A greater than T point mutation results in the substitution of glutamate for valine in the sixth amino acid position (or seventh, if the… Development of SCD depends on whether the ...
SAN DIEGO — A newly approved gene therapy product for sickle cell disease, lovotibeglogene autotemcel (lovo-cel, marketed as Lyfgenia), led to durable disease remissions for up to 5 years and almost ...
FOX 5 Atlanta on MSN
Gene therapy & health equity in Sickle Cell Awareness Month
Dr. Lakiea Bailey, Executive Director of the Atlanta-headquartered Sickle Cell Community Consortium, joined us for National ...
TIB MOLBIOL, a subsidiary of Roche Diagnostics, has launched the LightMix Newborn TREC/SMN1/HBB kit, an in vitro diagnostic test for newborn screening in countries accepting the CE mark. The LightMix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results